No significant difference was observed in plasma PCSK9 levels according to each ESSDAI component (i.e., lymphadenopathy, glandular, articular, pulmonary, renal, peripheral nervous system, central nervous system, hematological, biological) (p > 0.05 for all comparisons). The gene discussed is PCSK9; the disease is Lymphadenopathy.